These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 6716618)

  • 21. Fluosol-DA as a red-cell substitute in acute anemia.
    Gould SA; Rosen AL; Sehgal LR; Sehgal HL; Langdale LA; Krause LM; Rice CL; Chamberlin WH; Moss GS
    N Engl J Med; 1986 Jun; 314(26):1653-6. PubMed ID: 3713771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood substitutes: two ways to get there.
    Cowart VS
    JAMA; 1983 Jan; 249(2):159, 163-4. PubMed ID: 6848791
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of Fluosol-DA on pulmonary vessels.
    Nishimura N; Sugi T; Hiranuma N
    Prog Clin Biol Res; 1983; 122():283-9. PubMed ID: 6878371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survey of the effect of adding Fluosol-DA 20%/O2 to treatment with various chemotherapeutic agents.
    Teicher BA; Holden SA
    Cancer Treat Rep; 1987 Feb; 71(2):173-7. PubMed ID: 3100035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The influence of Fluosol-DA on the occurrence of lung metastases in Lewis lung carcinoma and B16 melanoma.
    Teicher BA; Jacobs JL; Kelley MJ
    Invasion Metastasis; 1988; 8(1):45-56. PubMed ID: 3343092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Experimental studies on the effect of perfluorochemicals in tumor irradiation].
    Shinoda J; Iwai T; Hattori T; Kondo H; Sakai N; Yamada H
    Gan No Rinsho; 1984 Jan; 30(1):53-8. PubMed ID: 6700116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Initial results of a clinical trial of Fluosol-DA 20 percent in acute cerebral ischemia.
    Swann KW; Ropper AH; Zervas NT
    Prog Clin Biol Res; 1983; 122():399-404. PubMed ID: 6348787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence for macrophage involvement in the enhancement of tumor growth delay with X-ray/Fluosol-DAR/O2 combination therapy.
    Holden SA; Teicher BA; McIntosh NL; Rose CM
    Anticancer Res; 1987; 7(3 Pt B):385-90. PubMed ID: 3115174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liquid-gas partition coefficients of halothane and isoflurane in perfluorodecalin, fluosol-DA, and blood/fluosol-DA mixtures.
    Tremper KK; Zaccari J; Cullen BF; Hufstedler SM
    Anesth Analg; 1984 Jul; 63(7):690-2. PubMed ID: 6731898
    [No Abstract]   [Full Text] [Related]  

  • 30. Fluosol-DA causes pulmonary hypertension and increased lung lymph flow in unanesthetized sheep.
    O'Brodovich H; Belbeck L; Andrew M; Coates G
    Clin Invest Med; 1985; 8(1):15-21. PubMed ID: 3987115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies of controlled reperfusion after ischemia. XIX. Reperfusate composition: benefits of blood cardioplegia over fluosol DA cardioplegia during regional reperfusion--importance of including blood components in the initial reperfusate.
    Acar C; Partington MT; Buckberg GD
    J Thorac Cardiovasc Surg; 1991 Feb; 101(2):284-93. PubMed ID: 1992239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of perfluorochemical fluosol-DA (20%) on myocardial infarct healing in the rabbit.
    Virmani R; Osmialowski AF; Kolodgie FD; Forman MB
    Am J Cardiovasc Pathol; 1990; 3(1):69-80. PubMed ID: 2331363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiosensitization of murine tumors by Fluosol-DA 20%.
    Lee I; Levitt SH; Song CW
    Radiat Res; 1990 Jun; 122(3):275-9. PubMed ID: 2113298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Choice of blood substitutes in Chicago.
    Cowart VS
    JAMA; 1983 Jan; 249(2):164, 166. PubMed ID: 6848792
    [No Abstract]   [Full Text] [Related]  

  • 35. Can "artificial blood' live up to public billing?
    Cowart VS
    JAMA; 1982 Feb; 247(8):1104-5. PubMed ID: 7057595
    [No Abstract]   [Full Text] [Related]  

  • 36. Experimental studies on the possible combined chemotherapy to neoplasms with Fluosol-DA infusion.
    Ohyanagi H; Nishijima M; Usami M; Nishimatsu S; Matsui E; Saitoh Y
    Prog Clin Biol Res; 1983; 122():315-20. PubMed ID: 6576383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Artificial blood.
    Lowe KC
    Br Med J (Clin Res Ed); 1983 Apr; 286(6371):1142-3. PubMed ID: 6404357
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of various oxygenation conditions on the enhancement by Fluosol-DA of melphalan antitumor activity.
    Teicher BA; Crawford JM; Holden SA; Cathcart KN
    Cancer Res; 1987 Oct; 47(19):5036-41. PubMed ID: 3113727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of Fluosol-DA hemodilution on the kinetics of hepatically eliminated drugs.
    Shrewsbury RP
    Res Commun Chem Pathol Pharmacol; 1987 Mar; 55(3):375-96. PubMed ID: 3575876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Morphology of the pig liver after Fluosol infusion].
    Petutschnigk D; Herrmann M; Hirlinger WK
    Z Mikrosk Anat Forsch; 1980; 94(5):908-12. PubMed ID: 7210801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.